NYXH - יחס שווי שוק לשווי בספרים Nyxoah, S.A.

Nyxoah S.A. is developing partnerships with specialized centers and implementing IT monitoring through merger and acquisition deals. The company's price chart demonstrates the asset's dynamics, while the metric currently stands at 0.90. The Belgian brand has earned physician recognition thanks to innovative nerve stimulation that replaces masks. Patents for apnea implants, successfully sold in the US and Europe, provide a competitive advantage.

This indicator measures the market premium over net assets, where the current value of 0.90 reflects investor valuation sensitivity to the fundamental margin of safety of Nyxoah S.A. (NYXH). The ratio demonstrates the extent to which the business value exceeds book capital, including costs for high-tech air delivery of implants, which is clearly interpreted through the dynamics of the market-to-book value ratio.